RxSight (RXST) Stock: Buy, Sell, or Hold?
$5.02
+0.11 (+2.35%)
▲
5d:
+0.5%
30d:
+10.71%
90d:
-28.46%
QUANTITATIVE VERDICT
BUY
HIGH Confidence (79%)
Quality Score
54/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$4.61 – $4.94
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-6.8x
Next 12M consensus est.
Wall Street Target
$6.10
+24.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$4.11 / $5.45
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
✅ BUY SIGNAL: RXST shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
Get Alerted When RXST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: RXST is currently trading at $5.01, which is considered slightly high relative to its 30-day fair value range of $4.61 to $4.94.
Technical Outlook: Technically, RXST is in a downtrend. Immediate support is located at $4.11, while resistance sits at $5.45.
Market Sentiment: RXST scores 74/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $6.10 (+24.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RXST is in a downtrend. Immediate support is located at $4.11, while resistance sits at $5.45.
Market Sentiment: RXST scores 74/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $6.10 (+24.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$4.61 -
$4.94
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.9%
Trading Range & Key Levels
30-Day Trading Range
$4.61 -
$4.94
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$4.11
Resistance Level
$5.45
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Strong technical setup (74/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 24.5% below Wall St target ($6.10)
- BULLISH: Bottoming setup score 74/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
-6.75
Wall Street Target
$6.10
(+24.5%)
Revenue Growth (YoY)
-19.0%
Profit Margin
-43.8%
Share RXST Analysis
Share this live RXST analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (RXST)
Bullish
3 Retail Mentions
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Jul 7, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages indicate bullish sentiment towards $RXST with traders seeing it as a good dip buy opportunity for Alcon, one of the biggest eye care companies globally.
Key Retail Themes:
Bullish outlook towards $RXST
Perception of $RXST as a good dip buy opportunity
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 12:57 PM ET
Data refreshes hourly during market hours. Next update: 1:57 PM
Data refreshes hourly during market hours. Next update: 1:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RXST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 52 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 38 SELL |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 31 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 38 SELL |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 39 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive RXST Research Pages
